Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

Autor: Ruth Lynfield, Lilith Tatham, Susan Bohm, Evan J. Anderson, Andrea George, Patrician A Ryan, Sandra S. Chaves, Shelley M Zansky, Nancy M. Bennett, Marisa Bargsten, Kimberly Yousey-Hindes, Mary Lou Lindegren, Carmen S. Arriola, Shikha Garg, Alicia M. Fry, Lisa Miller, Arthur Reingold, William Schaffner, Ann Thomas
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Aging
Severity of Illness Index
Medical and Health Sciences
law.invention
0302 clinical medicine
law
adults
Medicine
030212 general & internal medicine
Young adult
Vaccination
Middle Aged
Biological Sciences
Intensive care unit
Infectious Diseases
Influenza Vaccines
Pneumonia & Influenza
Female
disease severity
Infection
Human
Microbiology (medical)
Adult
medicine.medical_specialty
Adolescent
030106 microbiology
Microbiology
Article
Vaccine Related
03 medical and health sciences
Young Adult
Clinical Research
Internal medicine
Severity of illness
Influenza
Human

Humans
Propensity Score
Retrospective Studies
Aged
business.industry
Prevention
Retrospective cohort study
Odds ratio
Virology
Confidence interval
United States
Influenza
Influenza vaccination
Emerging Infectious Diseases
Propensity score matching
Immunization
business
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 65, iss 8
Popis: Background We investigated the effect of influenza vaccination on disease severity in adults hospitalized with laboratory-confirmed influenza during 2013-14, a season in which vaccine viruses were antigenically similar to those circulating. Methods We analyzed data from the 2013-14 influenza season and used propensity score matching to account for the probability of vaccination within age strata (18-49, 50-64, and ≥65 years). Death, intensive care unit (ICU) admission, and hospital and ICU lengths of stay (LOS) were outcome measures for severity. Multivariable logistic regression and competing risk models were used to compare disease severity between vaccinated and unvaccinated patients, adjusting for timing of antiviral treatment and time from illness onset to hospitalization. Results Influenza vaccination was associated with a reduction in the odds of in-hospital death among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95% confidence interval [CI], 0.05 to 0.97), 50-64 years (aOR = 0.48; 95% CI, 0.24 to 0.97), and ≥65 years (aOR = 0.39; 95% CI, 0.17 to 0.66). Vaccination also reduced ICU admission among patients aged 18-49 years (aOR = 0.63; 95% CI, 0.42 to 0.93) and ≥65 years (aOR = 0.63; 95% CI, 0.48 to 0.81), and shortened ICU LOS among those 50-64 years (adjusted relative hazards [aRH] = 1.36; 95% CI, 1.06 to 1.74) and ≥65 years (aRH = 1.34; 95% CI, 1.06 to 1.73), and hospital LOS among 50-64 years (aRH = 1.13; 95% CI, 1.02 to 1.26) and ≥65 years (aRH = 1.24; 95% CI, 1.13 to 1.37). Conclusions Influenza vaccination during 2013-14 influenza season attenuated adverse outcome among adults that were hospitalized with laboratory-confirmed influenza.
Databáze: OpenAIRE